BB's Stock Haven

[GotYourMoneyBaby]

Discovery Laboratories: Small Biotech Company With Multiple Prime Time Catalysts


Amidst buyout / partnership rumours from the top drug makers in the world, of the likes including Johnson & Johnson (NYSE:JNJ), Merck & Co. (NYSE:MRK) and Pfizer (NYSE:PFE), Discovery Laboratories is stepping up to the plate with some major upcoming company developments that could make this the next small cap home run play. Among the upcoming binary events: completion of BAT during May as the last step for FDA resubmission on its flagship product, phase 2 results for Acute Respiratory Failure in June, initiation of phase 2a trial for Cystic Fibrosis in 3Q10, and FDA submission of the flagship product, Surfaxin in the treatment of ARDS, during 1Q11. Make no mistake about it, there is serious room for growth as this 70M market cap company and Surfaxin is tapping into a $1.8 billion dollar market opportunity for Acute Respiratory Distress Syndrome, of which currently there are no drugs approved for treatment. What makes this story even more compelling is that Discovery has met and received response letters from the FDA a total of three times, all with minor requirements that have since been met and completed. As a well-capitalized company paired with strong fundamental and technical chart breakout potential, it is undeniable that its re-emergence as healthy NASDAQ listed company is right around the corner.

going to be crazy play next weeek imho....

http://www.themarketfinancial.com/discovery-laboratories-small-biotech-company-with-multiple-prime-time-catalysts/2544